de Lange E C, Danhof M, de Boer A G, Breimer D D
Leiden/Amsterdam Center for Drug Research, University of Leiden, Netherlands.
Brain Res Brain Res Rev. 1997 Sep 30;25(1):27-49. doi: 10.1016/s0165-0173(97)00014-3.
For the study of the pharmacokinetics of drugs in the brain a number of in vivo techniques is available, including autoradiography, imaging techniques, cerebrospinal fluid sampling and in vivo voltammetry, which all have their specific advantages and limitations. Intracerebral microdialysis is a relatively new in vivo technique. It permits monitoring of local concentrations of drugs and metabolites at specific sites in the brain which makes it an attractive tool for pharmacokinetic research. In the use of this technique a number of factors should be considered. These include: type of probe, surgical trauma, post-surgery interval, perfusion flow rate, as well as composition and temperature of the perfusion medium. In particular in studies on drug transport across the blood-brain barrier (BBB), effects of insertion of the probe on BBB functionality is important. It appears that BBB functionality is not significantly affected if surgical and experimental conditions are well-controlled. The relationship between dialysate concentrations and those in the extracellular fluid of the periprobe tissue, the recovery of the drug, depends on periprobe processes governing the actual concentration of the drug at that site. These include extracellular-microvascular exchange, metabolism, and diffusion of the drug. Several methods have been proposed to determine recovery values. In particular the no net flux method and the extended no net flux method are useful in practice. Several microdialysis studies on BBB transport of drugs are presented showing that intracerebral microdialysis is capable to assess local BBB transport profiles. Compared with other in vivo techniques, intracerebral microdialysis is the only (affordable) technique that offers the possibility to monitor local BBB transport of drugs in unanaesthetized animals, under physiological and pathological conditions.
对于研究药物在脑内的药代动力学,有多种体内技术可供使用,包括放射自显影、成像技术、脑脊液采样和体内伏安法,这些技术都有其特定的优点和局限性。脑内微透析是一种相对较新的体内技术。它允许监测脑内特定部位药物和代谢物的局部浓度,这使其成为药代动力学研究的一个有吸引力的工具。在使用该技术时,应考虑多个因素。这些因素包括:探针类型、手术创伤、术后间隔时间、灌注流速,以及灌注介质的成分和温度。特别是在研究药物跨血脑屏障(BBB)的转运时,探针插入对BBB功能的影响很重要。如果手术和实验条件得到良好控制,似乎BBB功能不会受到显著影响。透析液浓度与探针周围组织细胞外液浓度之间的关系,即药物的回收率,取决于控制该部位药物实际浓度的探针周围过程。这些过程包括细胞外 - 微血管交换、代谢和药物扩散。已经提出了几种方法来确定回收率。特别是无净通量法和扩展无净通量法在实际应用中很有用。本文介绍了几项关于药物BBB转运的微透析研究,表明脑内微透析能够评估局部BBB转运情况。与其他体内技术相比,脑内微透析是唯一一种(经济实惠的)能够在生理和病理条件下,对未麻醉动物体内药物的局部BBB转运进行监测的技术。